Another important contribution to the “early multi-modal vasopressors” concept - Ang II at NED <0.25mcg/kg/min nearly halved the risk of death! Great collaboration @pwierusz@BellomoRinaldo @JonathanChowMD @Crit_Care@SCCM@SOCCA_CritCare
https://t.co/N3aloRY70M
updated the IBCC sedation chapter based on this report using PO guanfacine to wean off dexmedetomidine.
an RCT would be ideal, but for now this seems like a safe & logical option for many patients. thanks to the authors 🙏🙏
https://t.co/uHe8htI1Wx
https://t.co/3x7MRQvKQs
🏃♀️ Exercise at night is optimal vs. morning?
💡 Evening exercise led to:
⬆️ weight loss & ⬆️ VO2 peak vs. morning exercise
Key paper- Please Retweet!
https://t.co/1OEVIbhEJw
TOP 10 CARDIAC ARREST TRIALS OF 2022 🫀⚡️
What a year for resuscitation science! 💥
➡️ I collected and summarized in this infographic 10 must-read randomized trials published in 2022 in the fields of cardiac arrest and CPR
🔗 https://t.co/KUpXJo4u59
#FOAMcc#ResusTwitter
In Vitro Activity of Cefepime-Taniborbactam and Comparators against Clinical Isolates of Gram-Negative Bacilli from 2018 to 2020 https://t.co/HWv4NmOu65
🔥Linezolid d/d Interactions and Serotonin syndrome 🔥
🆕️⚡️Population-based cohort study of 1134 patients who were prescribed linezolid,215 patients (19.0%) were taking antidepressants
Serotonin syndrome occurred in less than 0.5% of patients #IDTwitter
https://t.co/tiVlyY2QXt
🚨 Calling all lovers of Critical Care looking for a PGY2 residency 🚨 Check out @NorthwesternMed PGY2 Pharmacy Residency! Sign up via QR code below for informational session!
🚨🚨UAB Pharmacy Residency Programs will be holding a virtual open house Wednesday, November 9th from 2-3pm CST!! All our programs will be there!
https://t.co/SBGSaJ4Qss
#uabpharmreslife#pharmres#TwitteRx#PharmEd#OncoPharm
What is your preferred reversal agent for DOAC-associated ICH? 🧠🩸
A @CritCareMed SRMA "Andexanet Alfa or PCC for Factor Xa inhibitor Reversal in Acute Major Bleeding" found
▶️Similar hemostatic efficacy🩸
⤴️Thrombosis w/AA 💉
#NeuroICU#NeuroTwitter
https://t.co/tUa6H2dW0M
Pseudomonas resistance is… complicated. Check out this infographic by @littlebugdrug from a recent #Breakpoints episode and tune in to hear @erinmccreary, @aoliverp73, and @maggiemonogue discuss every detail. Listen now: https://t.co/XTxayI4EF8
Vanc + pip-taz was associated with an ⬆️risk of Cr-defined AKI, but not changes in alt kidney function biomarkers (cystatin C, BUN) or downstream clinical outcomes associated with true AKI (dialysis or mortality) #pseudotoxicity
https://t.co/RkHswf1yxN
I’d like to propose that when ordering antibiotics, if you select aspiration pneumonitis as the indication, a pop up triggers that says 🚨GOTCHA🚨and then the order exits.
#TwitteRx#Stewardship
Mild infections due to CRAB may be treated with high dose Amp-Sulbactam but moderate to severe infections should be double covered if possible. Table 1 in the guidelines discuss recommended agents. #CritPRN https://t.co/yuBeMCjZBw